78 related articles for article (PubMed ID: 22580283)
41. Par-4 is an essential downstream target of DAP-like kinase (Dlk) in Dlk/Par-4-mediated apoptosis.
Boosen M; Vetterkind S; Kubicek J; Scheidtmann KH; Illenberger S; Preuss U
Mol Biol Cell; 2009 Sep; 20(18):4010-20. PubMed ID: 19625447
[TBL] [Abstract][Full Text] [Related]
42. Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2.
Fang J; Menon M; Zhang D; Torbett B; Oxburgh L; Tschan M; Houde E; Wojchowski DM
Blood; 2008 Aug; 112(3):886-90. PubMed ID: 18535204
[TBL] [Abstract][Full Text] [Related]
43. DAPK2 regulates oxidative stress in cancer cells by preserving mitochondrial function.
Schlegel CR; Georgiou ML; Misterek MB; Stöcker S; Chater ER; Munro CE; Pardo OE; Seckl MJ; Costa-Pereira AP
Cell Death Dis; 2015 Mar; 6(3):e1671. PubMed ID: 25741596
[TBL] [Abstract][Full Text] [Related]
44. Death-associated protein kinase 2: Regulator of apoptosis, autophagy and inflammation.
Geering B
Int J Biochem Cell Biol; 2015 Aug; 65():151-4. PubMed ID: 26055515
[TBL] [Abstract][Full Text] [Related]
45. DAPk and pyruvate kinase: unlikely partners in cancer metabolic regulation.
Mor I; Bialik S; Kimchi A
Cell Cycle; 2012 Jan; 11(1):3-4. PubMed ID: 22157095
[No Abstract] [Full Text] [Related]
46. Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinase.
Brognard J; Zhang YW; Puto LA; Hunter T
Cancer Res; 2011 Apr; 71(8):3152-61. PubMed ID: 21487036
[TBL] [Abstract][Full Text] [Related]
47. Immunokinases, a novel class of immunotherapeutics for targeted cancer therapy.
Tur MK; Neef I; Jäger G; Teubner A; Stöcker M; Melmer G; Barth S
Curr Pharm Des; 2009; 15(23):2693-9. PubMed ID: 19689339
[TBL] [Abstract][Full Text] [Related]
48. Look for the Scaffold: Multifaceted Regulation of Enzyme Activity by 14-3-3 Proteins.
Obšilová V; Obšil T
Physiol Res; 2024 Apr; ():. PubMed ID: 38647170
[TBL] [Abstract][Full Text] [Related]
49. miR-520h is crucial for DAPK2 regulation and breast cancer progression.
Su CM; Wang MY; Hong CC; Chen HA; Su YH; Wu CH; Huang MT; Chang YW; Jiang SS; Sung SY; Chang JY; Chen LT; Chen PS; Su JL
Oncogene; 2017 Oct; 36(41):5770. PubMed ID: 28825723
[TBL] [Abstract][Full Text] [Related]
50. 14-3-3 proteins inactivate DAPK2 by promoting its dimerization and protecting key regulatory phosphosites.
Horvath M; Petrvalska O; Herman P; Obsilova V; Obsil T
Commun Biol; 2021 Aug; 4(1):986. PubMed ID: 34413451
[TBL] [Abstract][Full Text] [Related]
51. Novel Functions of Death-Associated Protein Kinases through Mitogen-Activated Protein Kinase-Related Signals.
Elbadawy M; Usui T; Yamawaki H; Sasaki K
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30287790
[TBL] [Abstract][Full Text] [Related]
52. Non-canonical activation of DAPK2 by AMPK constitutes a new pathway linking metabolic stress to autophagy.
Shiloh R; Gilad Y; Ber Y; Eisenstein M; Aweida D; Bialik S; Cohen S; Kimchi A
Nat Commun; 2018 May; 9(1):1759. PubMed ID: 29717115
[TBL] [Abstract][Full Text] [Related]
53. Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a discovery tool.
Wilson TJ; Zamler DB; Doherty R; Castro MG; Lowenstein PR
Oncotarget; 2016 Sep; 7(39):63020-63041. PubMed ID: 27564115
[TBL] [Abstract][Full Text] [Related]
54. Death-Associated Protein Kinase Activity Is Regulated by Coupled Calcium/Calmodulin Binding to Two Distinct Sites.
Simon B; Huart AS; Temmerman K; Vahokoski J; Mertens HD; Komadina D; Hoffmann JE; Yumerefendi H; Svergun DI; Kursula P; Schultz C; McCarthy AA; Hart DJ; Wilmanns M
Structure; 2016 Jun; 24(6):851-61. PubMed ID: 27133022
[TBL] [Abstract][Full Text] [Related]
55. Identification of Novel Death-Associated Protein Kinase 2 Interaction Partners by Proteomic Screening Coupled with Bimolecular Fluorescence Complementation.
Geering B; Zokouri Z; Hürlemann S; Gerrits B; Ausländer D; Britschgi A; Tschan MP; Simon HU; Fussenegger M
Mol Cell Biol; 2016 Jan; 36(1):132-43. PubMed ID: 26483415
[TBL] [Abstract][Full Text] [Related]
56. Nodes-and-connections RNAi knockdown screening: identification of a signaling molecule network involved in fulvestrant action and breast cancer prognosis.
Miyoshi N; Wittner BS; Shioda K; Hitora T; Ito T; Ramaswamy S; Isselbacher KJ; Sgroi DC; Shioda T
Oncogenesis; 2015 Oct; 4(10):e172. PubMed ID: 26479444
[TBL] [Abstract][Full Text] [Related]
57. Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria function.
Maimaitiyiming H; Li Y; Cui W; Tong X; Norman H; Qi X; Wang S
Am J Physiol Renal Physiol; 2013 Sep; 305(6):F881-90. PubMed ID: 23825069
[TBL] [Abstract][Full Text] [Related]
58. cGMP-dependent protein kinase I promotes cell apoptosis through hyperactivation of death-associated protein kinase 2.
Isshiki K; Matsuda S; Tsuji A; Yuasa K
Biochem Biophys Res Commun; 2012 Jun; 422(2):280-4. PubMed ID: 22580283
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
